Akin to halofuginone, flavonoid luteolin was reported to accelerate the turnover of NRF2 mRNA, leading to a marked reduction of its mRNA and protein levels and enhanced sensitivity of lung cancer cells to chemotherapeutic agents 120. This evidence concerns the gene NFE2L2 and lung carcinoma.